GSK, Belgium
GlaxoSmithKline (Employment)
OP-26A - Evaluation of the Potential Confounding Effect of Shingles on the Risk of Guillain-barré Syndrome After Vaccination with the Recombinant Zoster Vaccine
Monday, August 23, 20211:45 PM – 3:30 PM US Eastern Time